Global OTC Anti-Infective Drug Market Growth (Status and Outlook) 2024-2030

2024

Global OTC Anti-Infective Drug Market Growth (Status and Outlook) 2024-2030

Name: Global OTC Anti-Infective Drug Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001159
Price: 3450 USD
Availability: InStock
Rating: 5 (20 reviews)

The global OTC Anti-Infective Drug market, valued at US$ 22,020 million in 2024, is projected to grow with increasing demand for over-the-counter treatments for infections.

Bonafide Trust
24-09-2024
Pages : 113
Figures : 79
Tables : 103
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global over-the-counter (OTC) anti-infective drug market is experiencing significant growth, driven by increasing awareness about health issues, growing consumer preference for self-medication, and the rising prevalence of infectious diseases. OTC anti-infective drugs are widely available and provide an accessible and convenient option for individuals to manage mild infections without requiring a prescription. These drugs play a crucial role in the treatment of a wide range of conditions, such as colds, flu, fungal infections, and skin-related infections, contributing to the overall health and well-being of individuals. The market's expansion is also supported by the growing trend of self-care, particularly in developed countries where consumers have easy access to pharmacies and healthcare products. The increasing availability of OTC anti-infective medications across various retail channels, including drugstores, supermarkets, and e-commerce platforms, is further boosting the market's growth. The demand for OTC anti-infective drugs is also being fueled by the rising awareness of preventive healthcare, with many individuals choosing to manage mild infections at home rather than visiting healthcare providers. Furthermore, the COVID-19 pandemic has heightened the importance of hygiene, sanitization, and prevention of infectious diseases, driving greater reliance on OTC anti-infective drugs. As more people look for convenient and effective solutions to manage their health, the OTC anti-infective drug market continues to expand, offering a wide range of products such as antiseptics, disinfectants, antifungal agents, and antibiotics available without a prescription. Additionally, factors such as an increasing aging population, the rise of lifestyle diseases, and the expansion of healthcare access in emerging markets are contributing to the growing demand for OTC anti-infective medications worldwide.

According to Publisher, the global OTC Anti-Infective Drug market size was valued at US$ 22020 million in 2024. With growing demand in downstream market, the OTC Anti-Infective Drug is forecast to a readjusted size of US$ 39160 million by 2030 with a CAGR of 8.6% during review period. The market for OTC anti-infective drugs is experiencing rapid growth due to the increasing number of consumers who prefer to manage their health conditions independently. This trend is particularly prevalent in developed countries where individuals have access to information about over-the-counter medications and are more inclined to seek alternatives to prescription drugs. Consumers are becoming more knowledgeable about the benefits of OTC anti-infective products, especially in terms of convenience, cost-effectiveness, and ease of use. The rise in the self-medication trend is further supported by the availability of online resources and e-commerce platforms, allowing consumers to purchase OTC drugs from the comfort of their homes. Additionally, the growing awareness of personal hygiene and infection prevention, particularly in the aftermath of the COVID-19 pandemic, has led to an increased demand for OTC anti-infective products. Antiseptics and disinfectants, for example, have seen heightened demand as individuals take proactive measures to reduce the risk of infection. The convenience of OTC anti-infective drugs, coupled with the increased emphasis on preventive healthcare, has also contributed to the expansion of this market. Moreover, the growing preference for natural and homeopathic remedies is driving the development of new formulations of OTC anti-infective drugs that use herbal and organic ingredients. As consumers become more health-conscious, the demand for natural alternatives to traditional synthetic medications is rising, prompting companies to introduce OTC anti-infective products with natural antimicrobial agents. The OTC anti-infective drug market is also witnessing significant growth in emerging markets, where increasing healthcare awareness and greater access to retail pharmacies and online platforms are making it easier for consumers to purchase these products. As a result, the market is expected to continue expanding as self-care trends, preventive measures, and the availability of OTC drugs become more widespread across global regions.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The OTC anti-infective drug market is segmented into various product categories, including antiseptics, antifungal agents, antibiotics, and disinfectants. Among these, antiseptics hold a significant share of the market as they are commonly used to prevent and treat minor cuts, wounds, and infections. Antiseptic products, which include creams, ointments, gels, and sprays, are used to kill or inhibit the growth of microorganisms on the skin and mucous membranes, preventing infections. These products are widely used in households, hospitals, and clinics for wound care, and their demand is further supported by growing awareness about hygiene and infection prevention. The antiseptic segment is expected to maintain strong growth due to the increasing adoption of antiseptic products for everyday use, such as hand sanitizers, as consumers become more conscious of maintaining personal hygiene. In addition to antiseptics, antifungal agents are another prominent segment of the OTC anti-infective drug market. Fungal infections, such as athlete's foot, ringworm, and candidiasis, are common conditions that can be effectively treated with OTC antifungal medications. These medications come in the form of creams, powders, and sprays and are widely available without a prescription. The growth of the antifungal agents segment is driven by the increasing prevalence of fungal infections, particularly in warm and humid climates, as well as the rising demand for effective and accessible treatments for these conditions. Antibiotics, although more commonly associated with prescription medications, are also available in some OTC formulations for the treatment of mild infections such as sore throats, ear infections, and urinary tract infections. However, the use of antibiotics in OTC medications is regulated in many regions due to concerns about antibiotic resistance. Despite these concerns, the demand for OTC antibiotics remains steady, particularly for products that provide relief from common infections without requiring a doctor's visit. The disinfectant segment, which includes products like surface cleaners, sprays, and wipes, is also witnessing increased demand due to heightened awareness about hygiene and infection control. Disinfectants are widely used in homes, healthcare settings, and public spaces to reduce the spread of infectious agents, further driving the growth of the OTC anti-infective drug market.

The OTC anti-infective drug market is also segmented by application, with key areas of use including dermatological infections, respiratory infections, gastrointestinal infections, and urinary tract infections. Dermatological infections, such as fungal infections, cuts, wounds, and acne, represent a significant portion of the market, as OTC anti-infective products like creams, ointments, and antiseptic lotions are commonly used to treat these conditions. The rising prevalence of skin conditions, combined with the growing demand for accessible treatments, has contributed to the market growth in this segment. Respiratory infections, such as the common cold, flu, and sore throat, are also major contributors to the OTC anti-infective drug market. Products such as throat lozenges, cough syrups, and nasal sprays are commonly used to manage symptoms and alleviate discomfort caused by respiratory infections. The growing incidence of respiratory infections, especially during the colder months and flu season, is driving demand for OTC anti-infective medications in this category. Gastrointestinal infections, including conditions like diarrhea, food poisoning, and stomach infections, are treated with OTC anti-infective drugs such as antidiarrheal medications and antiemetics. These drugs help manage the symptoms of gastrointestinal infections, offering relief from nausea, vomiting, and diarrhea, and are commonly used by individuals seeking quick and effective treatments for these conditions. Lastly, urinary tract infections (UTIs) are also a significant area of focus in the OTC anti-infective drug market. UTIs are common, particularly among women, and OTC medications such as cranberry supplements and urinary antiseptics are used to treat mild infections and prevent recurrence. The increasing prevalence of UTIs, coupled with the growing consumer preference for self-care solutions, is expected to drive the continued growth of OTC anti-infective drugs in this segment. As the demand for self-medication and preventive healthcare continues to rise, the OTC anti-infective drug market is likely to expand across these diverse application areas, offering consumers a wide range of solutions for managing and preventing infections.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Drug Market Size 2019-2030
2.1.2 OTC Anti-Infective Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 OTC Anti-Infective Drug Segment by Type
2.2.1 Antifungal
2.2.2 Antibacterial
2.2.3 Antiviral
2.2.4 Antiseptics
2.2.5 Other
2.3 OTC Anti-Infective Drug Market Size by Type
2.3.1 OTC Anti-Infective Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
2.4 OTC Anti-Infective Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 OTC Anti-Infective Drug Market Size by Application
2.5.1 OTC Anti-Infective Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
3 OTC Anti-Infective Drug Market Size by Player
3.1 OTC Anti-Infective Drug Market Size Market Share by Players
3.1.1 Global OTC Anti-Infective Drug Revenue by Players (2019-2024)
3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2019-2024)
3.2 Global OTC Anti-Infective Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Drug by Regions
4.1 OTC Anti-Infective Drug Market Size by Regions (2019-2024)
4.2 Americas OTC Anti-Infective Drug Market Size Growth (2019-2024)
4.3 APAC OTC Anti-Infective Drug Market Size Growth (2019-2024)
4.4 Europe OTC Anti-Infective Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa OTC Anti-Infective Drug Market Size Growth (2019-2024)
5 Americas
5.1 Americas OTC Anti-Infective Drug Market Size by Country (2019-2024)
5.2 Americas OTC Anti-Infective Drug Market Size by Type (2019-2024)
5.3 Americas OTC Anti-Infective Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Drug Market Size by Region (2019-2024)
6.2 APAC OTC Anti-Infective Drug Market Size by Type (2019-2024)
6.3 APAC OTC Anti-Infective Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Anti-Infective Drug by Country (2019-2024)
7.2 Europe OTC Anti-Infective Drug Market Size by Type (2019-2024)
7.3 Europe OTC Anti-Infective Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Drug by Region (2019-2024)
8.2 Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC Anti-Infective Drug Market Forecast
10.1 Global OTC Anti-Infective Drug Forecast by Regions (2025-2030)
10.1.1 Global OTC Anti-Infective Drug Forecast by Regions (2025-2030)
10.1.2 Americas OTC Anti-Infective Drug Forecast
10.1.3 APAC OTC Anti-Infective Drug Forecast
10.1.4 Europe OTC Anti-Infective Drug Forecast
10.1.5 Middle East & Africa OTC Anti-Infective Drug Forecast
10.2 Americas OTC Anti-Infective Drug Forecast by Country (2025-2030)
10.2.1 United States OTC Anti-Infective Drug Market Forecast
10.2.2 Canada OTC Anti-Infective Drug Market Forecast
10.2.3 Mexico OTC Anti-Infective Drug Market Forecast
10.2.4 Brazil OTC Anti-Infective Drug Market Forecast
10.3 APAC OTC Anti-Infective Drug Forecast by Region (2025-2030)
10.3.1 China OTC Anti-Infective Drug Market Forecast
10.3.2 Japan OTC Anti-Infective Drug Market Forecast
10.3.3 Korea OTC Anti-Infective Drug Market Forecast
10.3.4 Southeast Asia OTC Anti-Infective Drug Market Forecast
10.3.5 India OTC Anti-Infective Drug Market Forecast
10.3.6 Australia OTC Anti-Infective Drug Market Forecast
10.4 Europe OTC Anti-Infective Drug Forecast by Country (2025-2030)
10.4.1 Germany OTC Anti-Infective Drug Market Forecast
10.4.2 France OTC Anti-Infective Drug Market Forecast
10.4.3 UK OTC Anti-Infective Drug Market Forecast
10.4.4 Italy OTC Anti-Infective Drug Market Forecast
10.4.5 Russia OTC Anti-Infective Drug Market Forecast
10.5 Middle East & Africa OTC Anti-Infective Drug Forecast by Region (2025-2030)
10.5.1 Egypt OTC Anti-Infective Drug Market Forecast
10.5.2 South Africa OTC Anti-Infective Drug Market Forecast
10.5.3 Israel OTC Anti-Infective Drug Market Forecast
10.5.4 Turkey OTC Anti-Infective Drug Market Forecast
10.5.5 GCC Countries OTC Anti-Infective Drug Market Forecast
10.6 Global OTC Anti-Infective Drug Forecast by Type (2025-2030)
10.7 Global OTC Anti-Infective Drug Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer OTC Anti-Infective Drug Product Offered
11.1.3 Bayer OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK OTC Anti-Infective Drug Product Offered
11.2.3 GSK OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva OTC Anti-Infective Drug Product Offered
11.3.3 Teva OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Teva Main Business Overview
11.3.5 Teva Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson OTC Anti-Infective Drug Product Offered
11.4.3 Johnson & Johnson OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 NOVARTIS
11.5.1 NOVARTIS Company Information
11.5.2 NOVARTIS OTC Anti-Infective Drug Product Offered
11.5.3 NOVARTIS OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 NOVARTIS Main Business Overview
11.5.5 NOVARTIS Latest Developments
11.6 MYLAN
11.6.1 MYLAN Company Information
11.6.2 MYLAN OTC Anti-Infective Drug Product Offered
11.6.3 MYLAN OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 MYLAN Main Business Overview
11.6.5 MYLAN Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma OTC Anti-Infective Drug Product Offered
11.7.3 Sun Pharma OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 CR SANJIU
11.8.1 CR SANJIU Company Information
11.8.2 CR SANJIU OTC Anti-Infective Drug Product Offered
11.8.3 CR SANJIU OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 CR SANJIU Main Business Overview
11.8.5 CR SANJIU Latest Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla OTC Anti-Infective Drug Product Offered
11.9.3 Cipla OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cipla Main Business Overview
11.9.5 Cipla Latest Developments
11.10 Lingrui
11.10.1 Lingrui Company Information
11.10.2 Lingrui OTC Anti-Infective Drug Product Offered
11.10.3 Lingrui OTC Anti-Infective Drug Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Lingrui Main Business Overview
11.10.5 Lingrui Latest Developments
12 Research Findings and Conclusion

Table 1. OTC Anti-Infective Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Antifungal
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antiseptics
Table 6. Major Players of Other
Table 7. OTC Anti-Infective Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global OTC Anti-Infective Drug Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Table 10. OTC Anti-Infective Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global OTC Anti-Infective Drug Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Table 13. Global OTC Anti-Infective Drug Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global OTC Anti-Infective Drug Revenue Market Share by Player (2019-2024)
Table 15. OTC Anti-Infective Drug Key Players Head office and Products Offered
Table 16. OTC Anti-Infective Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global OTC Anti-Infective Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global OTC Anti-Infective Drug Market Size Market Share by Regions (2019-2024)
Table 21. Global OTC Anti-Infective Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global OTC Anti-Infective Drug Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas OTC Anti-Infective Drug Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas OTC Anti-Infective Drug Market Size Market Share by Country (2019-2024)
Table 25. Americas OTC Anti-Infective Drug Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Table 27. Americas OTC Anti-Infective Drug Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Table 29. APAC OTC Anti-Infective Drug Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC OTC Anti-Infective Drug Market Size Market Share by Region (2019-2024)
Table 31. APAC OTC Anti-Infective Drug Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Table 33. APAC OTC Anti-Infective Drug Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Table 35. Europe OTC Anti-Infective Drug Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe OTC Anti-Infective Drug Market Size Market Share by Country (2019-2024)
Table 37. Europe OTC Anti-Infective Drug Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Table 39. Europe OTC Anti-Infective Drug Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa OTC Anti-Infective Drug Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa OTC Anti-Infective Drug Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa OTC Anti-Infective Drug Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Drug
Table 48. Key Market Challenges & Risks of OTC Anti-Infective Drug
Table 49. Key Industry Trends of OTC Anti-Infective Drug
Table 50. Global OTC Anti-Infective Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global OTC Anti-Infective Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global OTC Anti-Infective Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global OTC Anti-Infective Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Bayer Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 55. Bayer OTC Anti-Infective Drug Product Offered
Table 56. Bayer OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Bayer Main Business
Table 58. Bayer Latest Developments
Table 59. GSK Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 60. GSK OTC Anti-Infective Drug Product Offered
Table 61. GSK Main Business
Table 62. GSK OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GSK Latest Developments
Table 64. Teva Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 65. Teva OTC Anti-Infective Drug Product Offered
Table 66. Teva Main Business
Table 67. Teva OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Teva Latest Developments
Table 69. Johnson & Johnson Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 70. Johnson & Johnson OTC Anti-Infective Drug Product Offered
Table 71. Johnson & Johnson Main Business
Table 72. Johnson & Johnson OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Johnson & Johnson Latest Developments
Table 74. NOVARTIS Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 75. NOVARTIS OTC Anti-Infective Drug Product Offered
Table 76. NOVARTIS Main Business
Table 77. NOVARTIS OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. NOVARTIS Latest Developments
Table 79. MYLAN Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 80. MYLAN OTC Anti-Infective Drug Product Offered
Table 81. MYLAN Main Business
Table 82. MYLAN OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. MYLAN Latest Developments
Table 84. Sun Pharma Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 85. Sun Pharma OTC Anti-Infective Drug Product Offered
Table 86. Sun Pharma Main Business
Table 87. Sun Pharma OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Sun Pharma Latest Developments
Table 89. CR SANJIU Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 90. CR SANJIU OTC Anti-Infective Drug Product Offered
Table 91. CR SANJIU Main Business
Table 92. CR SANJIU OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. CR SANJIU Latest Developments
Table 94. Cipla Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 95. Cipla OTC Anti-Infective Drug Product Offered
Table 96. Cipla Main Business
Table 97. Cipla OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Cipla Latest Developments
Table 99. Lingrui Details, Company Type, OTC Anti-Infective Drug Area Served and Its Competitors
Table 100. Lingrui OTC Anti-Infective Drug Product Offered
Table 101. Lingrui Main Business
Table 102. Lingrui OTC Anti-Infective Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Lingrui Latest Developments

Figure 1. OTC Anti-Infective Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global OTC Anti-Infective Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. OTC Anti-Infective Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. OTC Anti-Infective Drug Sales Market Share by Country/Region (2023)
Figure 8. OTC Anti-Infective Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global OTC Anti-Infective Drug Market Size Market Share by Type in 2023
Figure 10. OTC Anti-Infective Drug in Hospital Pharmacies
Figure 11. Global OTC Anti-Infective Drug Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. OTC Anti-Infective Drug in Retail Pharmacies
Figure 13. Global OTC Anti-Infective Drug Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 14. OTC Anti-Infective Drug in Online Pharmacies
Figure 15. Global OTC Anti-Infective Drug Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global OTC Anti-Infective Drug Market Size Market Share by Application in 2023
Figure 17. Global OTC Anti-Infective Drug Revenue Market Share by Player in 2023
Figure 18. Global OTC Anti-Infective Drug Market Size Market Share by Regions (2019-2024)
Figure 19. Americas OTC Anti-Infective Drug Market Size 2019-2024 ($ Millions)
Figure 20. APAC OTC Anti-Infective Drug Market Size 2019-2024 ($ Millions)
Figure 21. Europe OTC Anti-Infective Drug Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa OTC Anti-Infective Drug Market Size 2019-2024 ($ Millions)
Figure 23. Americas OTC Anti-Infective Drug Value Market Share by Country in 2023
Figure 24. United States OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC OTC Anti-Infective Drug Market Size Market Share by Region in 2023
Figure 29. APAC OTC Anti-Infective Drug Market Size Market Share by Type in 2023
Figure 30. APAC OTC Anti-Infective Drug Market Size Market Share by Application in 2023
Figure 31. China OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 35. India OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe OTC Anti-Infective Drug Market Size Market Share by Country in 2023
Figure 38. Europe OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Figure 39. Europe OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Figure 40. Germany OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. France OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa OTC Anti-Infective Drug Market Size Market Share by Application (2019-2024)
Figure 48. Egypt OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country OTC Anti-Infective Drug Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 54. APAC OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 55. Europe OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 57. United States OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 58. Canada OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 59. Mexico OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 60. Brazil OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 61. China OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 62. Japan OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 63. Korea OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 65. India OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 66. Australia OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 67. Germany OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 68. France OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 69. UK OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 70. Italy OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 71. Russia OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 72. Spain OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 73. Egypt OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 74. South Africa OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 75. Israel OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 76. Turkey OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries OTC Anti-Infective Drug Market Size 2025-2030 ($ Millions)
Figure 78. Global OTC Anti-Infective Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global OTC Anti-Infective Drug Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted